Changing the sequence of therapies in prostate cancer: looking ahead

With the positive results from recent trials like SPARTAN (NCT01946204) and PROSPER (NCT02003924), it is likely that drugs typically associated with metastatic castration-resistant prostate cancer (mC... Author: VJOncology Added: 08/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts